Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · IEX Real-Time Price · USD
2.070
-0.180 (-8.00%)
At close: Jul 2, 2024, 4:00 PM
2.140
+0.070 (3.38%)
After-hours: Jul 2, 2024, 7:22 PM EDT
Omega Therapeutics Stock Forecast
OMGA's stock price has decreased by -56.96% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Omega Therapeutics stock have an average target of 10.4, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 402.42% from the current stock price of 2.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OMGA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $12 | Buy | Initiates | $12 | +479.71% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +479.71% | May 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +238.16% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +479.71% | Apr 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +334.78% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
4.54M
from 3.09M
Increased by 46.86%
Revenue Next Year
1.51M
from 4.54M
Decreased by -66.70%
EPS This Year
-1.30
from -1.80
EPS Next Year
-1.14
from -1.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.1M | 4.2M | 85.2M | 59.6M | 524.1M |
| Avg | 4.5M | 1.5M | 41.4M | 29.5M | 184.8M |
| Low | 2.4M | n/a | n/a | 3.2M | 9.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 96.8% | -7.6% | 5,531.1% | 44.0% | 1,675.0% |
| Avg | 46.9% | -66.7% | 2,635.1% | -28.7% | 525.9% |
| Low | -24.0% | - | - | -92.2% | -67.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.20 | -0.87 | -0.84 | -0.67 | 1.66 |
| Avg | -1.30 | -1.14 | -1.00 | -0.65 | 1.61 |
| Low | -1.34 | -1.30 | -1.15 | -0.63 | 1.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.